Altered activation of CYR61 gene enhancers occurs during CRC development, being CYR61 expression induced by FOXA1 and CBP in colon cancer cells pointing at both transcription factors as targets for CRC treatment (Xie et al., 2019). This evidence concerns the gene CCN1 and malignant colon neoplasm.